1. Home
  2. ITOS vs EXFY Comparison

ITOS vs EXFY Comparison

Compare ITOS & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • EXFY
  • Stock Information
  • Founded
  • ITOS 2011
  • EXFY 2008
  • Country
  • ITOS United States
  • EXFY United States
  • Employees
  • ITOS N/A
  • EXFY N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • EXFY Computer Software: Prepackaged Software
  • Sector
  • ITOS Health Care
  • EXFY Technology
  • Exchange
  • ITOS Nasdaq
  • EXFY Nasdaq
  • Market Cap
  • ITOS 270.7M
  • EXFY 253.2M
  • IPO Year
  • ITOS 2020
  • EXFY 2021
  • Fundamental
  • Price
  • ITOS $10.02
  • EXFY $2.21
  • Analyst Decision
  • ITOS Hold
  • EXFY Buy
  • Analyst Count
  • ITOS 6
  • EXFY 4
  • Target Price
  • ITOS $10.60
  • EXFY $4.75
  • AVG Volume (30 Days)
  • ITOS 2.6M
  • EXFY 478.8K
  • Earning Date
  • ITOS 04-28-2025
  • EXFY 05-08-2025
  • Dividend Yield
  • ITOS N/A
  • EXFY N/A
  • EPS Growth
  • ITOS N/A
  • EXFY N/A
  • EPS
  • ITOS N/A
  • EXFY N/A
  • Revenue
  • ITOS $35,000,000.00
  • EXFY $141,775,000.00
  • Revenue This Year
  • ITOS N/A
  • EXFY $7.77
  • Revenue Next Year
  • ITOS $31.74
  • EXFY $5.45
  • P/E Ratio
  • ITOS N/A
  • EXFY N/A
  • Revenue Growth
  • ITOS 177.89
  • EXFY N/A
  • 52 Week Low
  • ITOS $4.80
  • EXFY $1.24
  • 52 Week High
  • ITOS $18.13
  • EXFY $4.13
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 73.75
  • EXFY 35.69
  • Support Level
  • ITOS $8.30
  • EXFY $2.22
  • Resistance Level
  • ITOS $11.35
  • EXFY $2.50
  • Average True Range (ATR)
  • ITOS 0.53
  • EXFY 0.12
  • MACD
  • ITOS 0.22
  • EXFY -0.01
  • Stochastic Oscillator
  • ITOS 71.15
  • EXFY 13.43

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.

Share on Social Networks: